Clinical phenomenology of dystonia

International Review of Neurobiology

Volumn 98, Issue , 2011, Pages 509-524

  Colosimo, Carlo ^a   Berardelli, Alfredo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Blepharospasm; Dystonia; Meige's syndrome; Torticollis

Indexed keywords

AXIAL DYSTONIA; BLEPHAROSPASM; BOOK; CERVICAL DYSTONIA; CLINICAL FEATURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSTONIA; DYT1 GENE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; LIMB DYSTONIA; LINGUAL DYSTONIA; MEIGE SYNDROME; MENTAL DISEASE; MULTIFOCAL DYSTONIA; MUTATOR GENE; NONHUMAN; OROMANDIBULAR DYSTONIA; PATHOGENESIS; PHENOMENOLOGY; PRIORITY JOURNAL; RISK FACTOR; SPASMODIC DYSPHONIA; TORSIN 1A GENE;

EID: 80052524007     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381328-2.00018-3     Document Type: Chapter

References (57)

1. Abbruzzese G., Berardelli A., Girlanda P., Marchese R., Martino D., Morgante F., Avanzino L., Colosimo C., Defazio G. Long-term assessment of the risk of spread in primary late-onset focal dystonia. J. Neurol. Neurosurg. Psychiatry 2008, 79:392-396.
2. Albanese A., Lalli S. Is this dystonia?. Mov Disord 2009, 24:1725-1731.
3. Albanese A., Asmus F., Bhatia K.P., Elia A.E., Elibol B., Filippini G., Gasser T., Krauss J.K., Nardocci N., Newton A., Valls-Solé J. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur. J. Neurol. 2011, 18:5-18.
4. Anca M.H., Zaccai T.F., Badarna S., Lozano A.M., Lang A.E., Giladi N. Natural history of Oppenheim's dystonia (DYT1) in Israel. J. Child Neurol. 2003, 18:325-330.
5. Bader B., Walker R.H., Vogel M., Prosiegel M., McIntosh J., Danek A. Tongue protrusion and feeding dystonia: a hallmark of chorea-acanthocytosis. Mov. Disord. 2010, 25:127-129.
6. Berardelli A., Rothwell J.C., Day B.L., Marsden C.D. Pathophysiology of blepharospasm and oromandibular dystonia. Brain 1985, 108:593-608.
7. Berardelli A., Rothwell J.C., Hallett M., Thompson P.D., Manfredi M., Marsden C.D. The pathophysiology of primary dystonia. Brain 1988, 121:1195-1212.
8. Bhatia K.P., Quinn N.P., Marsden C.D. Clinical features and natural history of axial predominant adult onset primary dystonia. J. Neurol. Neurosurg. Psychiatry 1997, 63:788-791.
9. Calace P., Cortese G., Piscopo R., Volpe G.D., Gagliardi V., Magli A., De Berardinis T. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results. Eur. J. Ophthalm. 2003, 13:331-336.
10. Chan J., Brin M.F., Fahn S. Idiopathic cervical dystonia: clinical characteristics. Mov. Disord. 1991, 6:119-126.
11. Colosimo C., Pantano P., Calistri V., Totano P., Fabbrini G., Berardelli A. Diffusion tensor imaging in primary cervical dystonia. J. Neurol. Neurosurg. Psychiatry 2005, 76:1591-1593.
12. Colosimo C., Suppa A., Fabbrini G., Bologna M., Berardelli A. Craniocervical dystonia: clinical and pathophysiological features. Eur. J. Neurol. 2010, 17(Suppl 1):15-21.
13. Colosimo C., Fabbrini G., Berardelli Progressive supranuclear palsy. Handbook of Atypical Parkinsonism 2011, Cambridge University Press, Cambridge. C. Carlo, R. David E., W. Gregor K. (Eds.).
14. Defazio G., Berardelli A., Hallett M. Do primary adult-onset focal dystonias share aetiological factors?. Brain 2007, 130:1183-1193. Review.
15. Edwards M., Wood N., Bhatia K. Unusual phenotypes in DYT1 dystonia: a report of five cases and a review of the literature. Mov. Disord. 2003, 18:706-711.
16. Fabbrini G., Defazio G., Colosimo C., Thompson P.D., Berardelli A. Cranial movement disorders: clinical features, pathophysiology, differential diagnosis and treatment. Nat. Clin. Pract. Neurol. 2009, 5:93-105.
17. Fabbrini G., Berardelli I., Moretti G., Pasquini M., Bloise M., Colosimo C., Biondi M., Berardelli A. Psychiatric disorders in adult-onset focal dystonia: a case-control study. Mov. Disord. 2010, 25:459-465.
18. Factor S.A., Troche-Panetto M., Weaver S.A. Dystonia in AIDS: report of four cases. Mov. Disord. 2003, 18:1492-1498.
19. Fahn S. Classification and investigation of dystonia. Movement disorders 1987, 2:332-358. Butterworths, London.
20. Fahn, S. and Williams, D. (1988). Psychogenic dystonia. In: Dystonia 2 (S. Fahn, C.D. Marsden, and D.B. Calne, eds.), Advances in Neurology, vol. 50, Raven, New York, pp. 431-455.
21. Grandas F., Elston J., Quinn N., Marsden C.D. Blepharospasm: a review of 264 patients. J. Neurol. Neurosurg. Psychiatry 1988, 51:767-772.
22. Gupta A., Lang A.E. Psychogenic movement disorders. Curr. Opin. Neurol. 2009, 22:430-436. Review.
23. Hughes A.J., Lees A.J., Marsden C.D. Paroxysmal dystonic head tremor. Mov. Disord. 1991, 6:85-86.
24. Jahanshahi M., Marsden C.D. Depression in torticollis: a controlled study. Psych. Medicine 1988, 18:925-933.
25. Jahanshahi M., Marsden C.D. A longitudinal study of depression, disability and body concept in torticollis. Behav. Neurol. 1990 a, 3:233-246.
26. Jahanshahi M., Marsden C.D. Body concept, depression and disability in spasmodic torticollis. Behav Neurol 1990 b, 3:117-131.
27. Jankovic J. Treatment of dystonia. Lancet Neurol. 2006, 5:864-872.
28. Jankovic J., Orman J. Blepharospasm: demographic and clinical survey of 250 patients. Ann. Ophthalmol. 1984, 16:371-376.
29. Jankovic J., Orman J. Botulinum. A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology 1987, 37:616-623.
30. Jayne D., Lees A.J., Stern G.M. Spontaneous remission in spasmodic torticollis. J. Neurol. Neurosurg. Psychiatry 1984, 47:1236-1237.
31. Kurlan, R., Behr, J., Medved, L., and Shoulson, I. (1988). Myoclonus and dystonia: a family study. In: Dystonia 2 (S. Fahn, C.D. Marsden, and D.B. Calne, eds.), Advances in Neurology, vol. 50, Raven, New York, pp. 385-389.
32. LeDoux M.S. Meige syndrome: what's in a name?. Parkinsonism Relat. Disord. 2009, 15:483-489. Review.
33. Lesser R.P., Fahn S. Dystonia: a disorder often misdiagnosed as a conversion reaction. Am. J. Psychiatry 1978, 153:349-452.
34. Lowenstein D.H., Aminoff M.J. The clinical course of spasmodic torticollis. Neurology 1988, 38:530-532.
35. Marsden C.D. Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia?. J. Neurol. Neurosurg. Psychiatry. 1976, 39:1204-1209.
36. Marsden, C.D. (1976b). The problem of adult-onset idiopathic torsion dystonia and other isolated dyskinesias in adult life (including blepharospasm, oromandibolar dystonia, dystonic writer's cramp, and torticollis, or axial dystonia). In: Dystonia (R. Eldridge and S. Fahn, eds.), Advances in Neurology, vol. 14, Raven, New York, pp. 259-276.
37. Marsden C.D., Harrison M.J.G. Idiopatic torsion dystonia (dystonia muscolorum deformans): a review of forty-two patients. Brain 1974, 97:793-810.
38. Marsden C.D., Obeso J.A., Zarranz J.J., Lang A.E. The anatomical basis of symptomatic hemidystonia. Brain 1985, 108:463-483.
39. Martino D., Macerollo A., Abbruzzese G., Bentivoglio A.R., Berardelli A., Esposito M., Fabbrini G., Girlanda P., Guidubaldi A., Liguori R., Liuzzi D., Marinelli L., Morgante F., Sabetta A., Santoro L., Defazio G. Lower limb involvement in adult-onset primary dystonia: frequency and clinical features. Eur. J. Neurol. 2010, 17:242-246.
40. Meige H. Les convulsions de la face. Une forme clinique de convulsion faciale bilaterale et mediane. Rev. Neurol. (Paris) 1910, 21:437-443.
41. Müller J., Kemmler G., Wissel J., et al. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J. Neurol. 2002, 249:842-846.
42. Murry T., Cannito M.P., Taylor M., Bender B. Spasmodic dysphonia. Emotional status and botulinum toxin treatment. Arch. Otolaryngol. Head Neck Surg. 1994, 120:310-316.
43. Nutt, J.G., Muenter, M.D., Melton, J., et al. (1988). Epidemiology of dystonia in Rochester, Minnesota. In: Dystonia 2 (a cura di S. Fahn, C.D. Marsden, and D.B. Calne, eds.), Advances in Neurology, vol. 50, Raven, New York, pp. 361-365.
44. Oppenheim H. Über eine eigenartige Krampfkrankheit des kindlichen und jugendlichen Alters (Dysbasia lordotica progressiva, dystonia muscolorum deformans). Neurologische Centralblatt 1911, 30:1090-1107.
45. Ozelius L.J., Kramer P.L., de Leon D., et al. Strong allelic association between the torsion dystonia gene (DYT1) and loci on chromosome 9q34 in Ashkenazi Jews. Am. J. Hum. Genet. 1992, 50:619-628.
46. Papathanasiou I., MacDonald L., Whurr R., Jahanshahi M. Perceived stigma in spasmodic torticollis. Mov. Disord. 2001, 16:280-285.
47. Paulson G.W. Meige's syndrome. Dyskinesia of the eyelids and facial muscles. Geriatrics 1972, 8:69-73.
48. Perlmutter J.S., Stambuk M.K., Markham J., Black K.J., McGee-Minnich L., Jankovic J., Moerlein S.M. Decreased 18F spiperone binding in putamen in idiopathic focal dystonia. J. Neurosci. 1997, 17:843-850.
49. Pettigrew L.C., Jankovic J. Hemidystonia: a report of 22 patients and a review of the literature. J. Neurol. Neurosurg. Psychiatry 1985, 48:650-657.
50. Quinn, N.P., Rothwell, J.C., Thompson, P.D., and Marsden, C.D. (1988). Hereditary myoclonic dystonia, hereditary torsion dystonia and ereditary essential myoclonus: an area of confusion. In: Dystonia 2 (S. Fahn, C.D. Marsden, and D.B. Calne, eds.), Advances in Neurology, vol. 50, Raven, New York, pp. 391-401.
51. Roze E., Soumaré A., Pironneau I., Sangla S., de Cock V.C., Teixeira A., Astorquiza A., Bonnet C., Bleton J.P., Vidailhet M., Elbaz A. Case-control study of writer's cramp. Brain 2009, 132:756-764.
52. Schneider S.A., Aggarwal A., Bhatt M., Dupont E., Tisch S., Limousin P., Lee P., Quinn N., Bhatia K.P. Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology. 2006, 67:940-943.
53. Schneider S.A., Edwards M.J., Mir P., Cordivari C., Hooker J., Dickson J., Quinn N., Bhatia K.P. Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov. Disord. 2007, 22:2210-2215.
54. Segawa M. Hereditary progressive dystonia with marked diurnal fluctuation. Brain Dev. 2010 Nov 19, [Epub ahead of print].
55. Tinazzi M., Squintani G., Berardelli A. Does neurophysiological testing provide the information we need to improve the clinical management of primary dystonia?. Clin. Neurophysiol. 2009, 120:1424-1432.
56. Tolosa E. Drug induced dyskinesia. Parkinson's Disease and Movement Disorders 1993, 375-397. Lippincott Williams & Wilkins, Baltimore. edn 2. J. Jankovic, E. Tolosa (Eds.).
57. Ward A.B., Molenaers G., Colosimo C., Berardelli A. Clinical value of botulinum toxin in neurological indications. Eur. J. Neurol. 2006, 13:20-26.